1. Home
  2. VBIV

VBIV

VBI Vaccines Inc. New (Canada)

Logo VBI Vaccines Inc. New (Canada)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 11:33am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 17.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 456.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.03 EPS Growth: N/A
52 Week Low/High: $0.45 - $3.86 Next Earning Date: 04-16-2024
Revenue: $8,682,000 Revenue Growth: 702.40%
Revenue Growth (this year): 133.1% Revenue Growth (next year): 58.23%

Share on Social Networks: